PATENT CLAIM ANALYSIS

Application Number: 16382726
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-10
Patent Classification: ["514", "049000"]

Abstract:
Methods for treating cancer by administration of two or more therapeutic agents are provided. The two or more therapeutic agents include a cyclin-dependent kinase inhibitor (e.g., alvocidib) and an anthracycline (e.g., daunorubicin or idarubicin). Kits comprising the two or more therapeutic agents that can be used to perform such methods are also provided.

Claim (Index 27):
The method of  claim 26 , comprising administering to the subject a treatment comprising:\n from about 5 mg/m 2  to about 50 mg/m 2  alvocidib, or a pharmaceutically acceptable salt thereof, per day, administered by an intravenous bolus of from about 10 minutes to about 60 minutes in duration, and from about 10 mg/m 2  to about 65 mg/m 2  alvocidib, or a pharmaceutically acceptable salt thereof, per day, administered by intravenous infusion of about 4 hours in duration, wherein the intravenous bolus and the intravenous infusion of alvocidib, or a pharmaceutically acceptable salt thereof, are administered to the subject on the first, second and third days of the treatment, and the intravenous infusion is initiated about 30 minutes after completion of the intravenous bolus; about 60 mg/m 2  daunorubicin, or a pharmaceutically acceptable salt thereof, per day, administered by intravenous bolus of from about 5 minutes to about 30 minutes in duration on the fifth, sixth and seventh days of the treatment; and about 100 mg/m 2  cytarabine, or a pharmaceutically acceptable salt thereof, per day, administered by intravenous infusion of from about 20 hours to about 28 hours in duration on the fifth, sixth, seventh, eighth, ninth, tenth, and eleventh days of the treatment.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 100.0
- Lexical Diversity: 1.44186
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12730097', '11811626', '12032583', '14315930', '14009021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7275960094283058
- 35 USC 102 Novelty (BERT): 0.5280093128690416
- Combined Prediction Score: 0.7076373397723794
- Mean Citation Score: 273.01801600000005
- Max Citation Score: 319.75333
- Similarity Product: 220.7217174511945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test